Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
ConclusionWhether ivermectin has an added value in reducing the frequency of seizures in PWE treated with AED remains to be determined. A larger study in persons with OAE on a stable AED regimen and in persons with recent epilepsy onset should be considered to further investigate the potential beneficial effect of ivermectin treatment in persons with OAE. Trial registrationRegistration: www.clinicaltrials.gov; NCT03052998.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Michel Mandro Source Type: research
More News: Clinical Trials | Congo Health | Endemics | Epilepsy | Men | Phenobarbital | River Blindness | Study | Tropical Medicine